Evommune, Inc. (NYSE: EVMN) last traded at $6.09, down 2.56% on the session. The quote above updates while this page is open; the figures below are drawn from Evommune, Inc.’s own filings and are restated only when a new one is published.
Evommune, Inc. trades on NYSE under the ticker EVMN. Its market capitalisation is $221.02 million.
Valuation measures for Evommune, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $221.02M |
|---|---|
| Enterprise value | $185.35M |
| Price / sales | 22.10 |
| Price / book | 0.80 |
| Beta | 0.95 |
Trailing-twelve-month figures tagged in Evommune, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $10.00M |
| Net income (TTM) | -$94.67M |
|---|
| Operating margin | -1018.94% |
|---|
| Return on equity | -34.10% |
|---|
| Cash | $60.03M |
|---|
Range and volume for EVMN over the past 52 weeks.
| 52-week high | $33.20 |
|---|---|
| 52-week low | $6.02 |
| Volume | 186.5K |
| Average volume | 678.1K |
| Previous close | $6.25 |
Invest a chosen dollar amount in Evommune, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell EVMN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.